Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas

被引:35
作者
Lin, Shaojun [1 ,2 ,3 ]
Guo, Qiaojuan [1 ,2 ,3 ]
Wen, Jiangmei [1 ,2 ,3 ]
Li, Chao [3 ,4 ]
Lin, Jin [1 ,2 ,3 ]
Cui, Xiaofei [1 ,2 ,3 ]
Sang, Nianli [5 ,6 ]
Pan, Jianji [1 ,2 ,3 ]
机构
[1] Fujian Prov Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China
[2] Fujian Prov Canc Hosp, Prov Clin Coll, Fuzhou, Fujian, Peoples R China
[3] Fujian Prov Key Lab Translat Canc Med, Fuzhou, Fujian, Peoples R China
[4] Fujian Prov Canc Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China
[5] Drexel Univ, Coll Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA
[6] Drexel Univ, Coll Arts & Sci, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
来源
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 2014年 / 33卷
关键词
Nasopharyngeal carcinoma; Radiation therapy; Stanniocalcin 2 (STC2); Biomarker; Prognosis; Retrospective; Metastasis; COMPARING NEOADJUVANT CHEMOTHERAPY; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; CLINICAL-SIGNIFICANCE; GENE-EXPRESSION; OVARIAN-CANCER; PHASE-III; IN-VITRO; RADIOTHERAPY; MARKER;
D O I
10.1186/1756-9966-33-26
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Stanniocalcin 2 (STC2) is overexpressed in several types of human cancers, and its overexpression positively correlates to tumor progression and poor prognosis. However, the clinical significance of STC2 overexpression in nasopharyngeal carcinomas (NPC) has not been investigated. This study examined STC2 expression in a cohort of 94 NPC samples, and explored its value in clinical diagnosis and prognosis. Methods: Tumor samples from 94 patients diagnosed in 2008 were studied. All samples were obtained prior to treatment start. All cases were clinically diagnosed and pathologically confirmed to be poorly differentiated or undifferentiated NPC without distant metastasis, and have been treated with radical radiation therapy and followed-up for five years. Survival analyses were performed. Results: Of the 94 NPC samples, STC2 overexpression (STC2+) was detected in 65 samples (69.1%). Overall survival rate of STC2 (+) patients is significantly lower than that of patients with normal STC2 levels (72.2% vs. 96.4%, respectively, P = 0.049). Moreover, STC2 (+) is also strongly predictive of a low progression-free survival and distant metastasis-free survival (63.0% vs 92.9%. P = 0.007; and 77.0% vs 96.4%. P = 0.028). Of the 54 patients treated with IMRT, residual tumors were found in 54.8% of STC2 positive patients (17/31), but only in 17.4% of STC2 negative ones (4/23), suggesting STC2 overexpression predicts a higher risk of residual tumors after IMRT. Conclusions: STC2 overexpression correlates to poor prognosis for NPC and may be useful as a novel biomarker to predict NPC responses to radiation. Whether STC2 promotes NPC progression and metastasis remains to be investigated.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Combined Runx2 and Snail overexpression is associated with a poor prognosis in breast cancer
    Yang, Zhengjun
    Zhang, Bin
    Liu, Bowen
    Xie, Yegong
    Cao, Xuchen
    TUMOR BIOLOGY, 2015, 36 (06) : 4565 - 4573
  • [32] Overexpression of RhoGDI2 Correlates with Tumor Progression and Poor Prognosis in Colorectal Carcinoma
    Li, Xianzheng
    Wang, Jianmei
    Zhang, Xiaojing
    Zeng, Yuanfeng
    Liang, Li
    Ding, Yanqing
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) : 145 - 153
  • [33] Overexpression of UBE2C correlates with poor prognosis in gastric cancer patients
    Zhang, H. -Q.
    Zhao, G.
    Ke, B.
    Ma, G.
    Liu, G. -L.
    Liang, H.
    Liu, L. -R.
    Hao, X. -S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1665 - 1671
  • [34] Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy
    Topkan, Erkan
    Yucel Ekici, Nur
    Ozdemir, Yurday
    Besen, Ali Ayberk
    Mertsoylu, Huseyin
    Sezer, Ahmet
    Selek, Ugur
    ENT-EAR NOSE & THROAT JOURNAL, 2021, 100 (02) : NP69 - NP76
  • [35] Expression of bcl-2 correlates with poor prognosis and modulates migration of nasopharyngeal carcinoma cells
    Chen, Mu-Kuan
    Yang, Shun-Fa
    Lai, Jui-Chung
    Yeh, Kun-Tu
    Yang, Jia-Sin
    Chen, Li-Sheng
    Chen, Hui-Chuan
    CLINICA CHIMICA ACTA, 2010, 411 (5-6) : 400 - 405
  • [36] Overexpression of cyclin E messenger ribonucleic acid in nasopharyngeal carcinoma correlates with poor prognosis
    Ko, M-T
    Su, C-Y
    Huang, S-C
    Chen, C-H
    Hwang, C-F
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2009, 123 (09) : 1021 - 1026
  • [37] Over-expression of protein tyrosine phosphatase 4A2 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma
    Gao, Ying
    Zhang, Mengping
    Zheng, Zhousan
    He, Ying
    Zhu, Yujia
    Cheng, Quanyong
    Rong, Jian
    Weng, Huiwen
    Chen, Cui
    Xu, Yi
    Yun, Miao
    Zhang, Jiaxing
    Ye, Sheng
    ONCOTARGET, 2017, 8 (44) : 77527 - 77539
  • [38] EZH2 overexpression is associated with poor prognosis in patients with glioma
    Zhang, Yanyang
    Yu, Xinguang
    Chen, Ling
    Zhang, Zhibin
    Feng, Shiyu
    ONCOTARGET, 2017, 8 (01) : 565 - 573
  • [39] SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
    Chuang, Hao-Wen
    Hsia, Kan-Tai
    Liao, Jia-Bin
    Yeh, Chih-Ching
    Kuo, Wei-Ting
    Yang, Yi-Fang
    DIAGNOSTICS, 2021, 11 (10)
  • [40] Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
    Lu, Wenjie
    Zang, Rukun
    Du, Yuanna
    Li, Xinghua
    Li, Hongwei
    Liu, Chuan
    Song, Yipeng
    Li, Yuncheng
    Wang, Yang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 11095 - 11102